Correction to “Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy”

• Haneen Abuzaid,
• Salah Abdelrazig,
• Lenny Ferreira,
• Hilary M. Collins,
• Dong-Hyun Kim,
• Kuan-Hon Lim,
• Toh-Seok Kam,
• Neil R. Thomas,
• Lyudmila Turyanska,
• Tracey D. Bradshaw

Affiliations

Haneen Abuzaid

School of Pharmacy, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Salah Abdelrazig

School of Pharmacy, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Lenny Ferreira

School of Chemistry, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Hilary M. Collins

School of Pharmacy, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Dong-Hyun Kim

School of Pharmacy, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Kuan-Hon Lim

The University of Nottingham Malaysia, Semenyih, Selangor, Malaysia

Toh-Seok Kam

Department of Chemistry, Faculty of Science, The University of Malaya, Kuala Lumpur, Malaysia

Neil R. Thomas

School of Chemistry, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.

Lyudmila Turyanska

Faculty of Engineering, The University of Nottingham, Nottingham, U.K.

Tracey D. Bradshaw

School of Pharmacy, Biodiscovery Institute, The University of Nottingham, Nottingham, U.K.